ABSTRACT. An Escherichia coli derived somatomedin-C/IGF-I preparation (rec-IGF-I) with an amino acid sequence identical to the natural IGF-I derived from human plasma, increases body length and weight, as well as the growth of several organs of Snell dwarf mice, when administered for 4 wk. After 2 wk of treatment rec-IGF-I (22.2 ~g/day) induced a significant increase over buffer treated controls, to a comparable degree as obtained with bacterially synthesized human growth hormone (bhGH, 8.4 pg/ day). The weightjlength ratio of rec-IGF-I and bhGHtreated dwarf mice after 4 wk of treatment were not significantly different. A significant increase over controls was obtained with both preparations. Organs with increased weights after bhGH treatment (brain; submandibular salivary glands; heart, liver, kidneys, thymus, and spleen) were also heavier after rec-IGF-I. Significance was only reached for the kidneys and the spleen and the musculus quadriceps femoris. Organ weights expressed as a percentage of body weight of bhGH and rec-IGF-I treated dwarfs were similar except for the relative weight of the heart of the bhGH group, which was significantly increased compared to the controls and the rec-IGF-I group. These data resolve the issue as to whether or not pure SM-C/IGF-I will induce growth in length and demonstrate the usefulness of recombinant IGF-I in the studies of growth regulation. (Pediatr Res 20: 825-827,1986) Abbreviations SM, somatomedins IGF, insulin-like growth factors bhGH, bacterially synthesized human N-terminal methionyl growth hormone SM or IGF are thought to mediate the effects of growth hormone on body growth (1, 2). Partially purified SM-preparations have been shown to increase body length and weight as well as the growth of many organs of Snell dwarf mice (3, 4), deficient in growth hormone and thyroid-stimulating hormone. In addition these preparations had stimulatory effects on the 35S-
SM, somatomedins IGF, insulin-like growth factors bhGH, bacterially synthesized human N-terminal methionyl growth hormone SM or IGF are thought to mediate the effects of growth hormone on body growth (1, 2) . Partially purified SM-preparations have been shown to increase body length and weight as well as the growth of many organs of Snell dwarf mice (3, 4) , deficient in growth hormone and thyroid-stimulating hormone. In addition these preparations had stimulatory effects on the 35S- ' Present address Fujisawa Pharmaceutical Co. Ltd., 1-6. 2-Chome, Kashima, Yodogawa-Ku, Osaka 532, Japan.
sulphate and 3H-methylthymidine incorporation into their costal cartilage, osteochondral junction, and epiphyseal cartilage. Further purified SM-C/IGF/I has been reported to increase body weight of hypophysectomized rats as well as the incorporation of thymidine in epiphyseal cartilage (5, 6) . However, the question if pure SM-C/IGF-I will also stimulate true skeletal growth as evidenced by an increase in body length has still not been resolved. In addition it is important to know whether or not overall harmony of body growth is maintained as evidenced by the weightllength relationship and the growth of different organs as is essentially the case with growth hormone (7, 8) . Scarcity of purified material has hampered extensive studies of the physiological actions of the somatomedins. The recent availability of larger quantities of SM-C/IGF-I synthesized by recombinant DNA technology (9-1 3) now facilitates such studies. Several analogues of biosynthetic SM-C/IGF-I displayed biological activities similar to SM-C/IGF-I extracted from human plasma derivatives (9, (14) (15) (16) . No data are available concerning the effect of such preparations on body growth. Herein we report the effects of an Escherichia coli derived IGF-I preparation with an amino acid sequence identical to the natural IGF-I on body length and weight, and the growth of several organs of Snell dwarf mice.
MATERIALS AND METHODS
Snell mice were kept under standardized laboratory conditions (28" C, humidity 60%) as described earlier (7). Dwarfs were bred by mating heterozygous parents (dw/+) and by mating heterozygous females to dwarf mice (dw/dw), rendered fertile by treatment with 1 pg L-thyroxine (Sigma, St. Louis, MO) and 50 pg ovine prolactin (Sigma) 5 days a week for at least 3 wk. After weaning at 4-5 wk the dwarfs were maintained on a diet of commercial food pellets, supplemented with a mixture of milk powder, wheat embryo, and raw egg (1:2:2) suspended in 10% glucose in water. All animals were weighed and the total length was measured weekly by the method of Hughes and Tanner (17) under ether anaesthesia. Groups consisted of five animals (3 $6, 2 99, age 6-8 wk) selected such as to obtain equal means and SDs for length and weight.
High protein liquid chromatography pure biosynthetic IGF-I (rec-IGF-I) was from Fujisawa (Osaka, Japan) (1 3). The specific activity of rec-IGF-I in the radioimmunoassay is 30,000 U/mg. The antiserum is distributed for research use by the National Hormone and Pituitary Distribution Programme of the NIADDK. The effect of bhGH (Abkabi, Stockholm, Sweden; 2 U/mg) on growth of dwarf mice is identical to the effect obtained with hGH derived from cadaver pituitary glands (1 8). All preparations were dissolved in saline and 0.04 M phosphate buffer (2:l) with 0.1 % human serum albumin (Sigma). The pH was adjusted with 0.1 N NaOH to 7.4 (phosphate buffer).
Animals received 0.1 ml phosphate buffer per injection sup-826 VAN 
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plemented with 2.8 pg bhGH, 1.85, 3.7, or 7.4 pg rec-IGF-I with 1.85,3.7, and 7.4 pg rec-IGF-I were 8.6,7.0, and 8.0 mmol/ subcutaneously, three times daily, 5 days a week for 4 wk. Buffer liter, respectively. They were slightly lower than those obtained alone served as a control. in sera of buffer and bhGH-treated animals (10.6 and 10.6 Body length and weight were measured once per week under mmol/liter, respectively). light ether anesthesia. After treatment animals were killed by decapitation under ether anaesthesia. For measuring blood glu-DISCUSSION cose levels sera were collected and pooled per group. Organs were removed and weighed to the nearest mg. Statistical analysis of Our results demonstrate for the first time that an E. coli derived the results was performed according to the S-method of ScheR IGF-I preparation with an amino acid sequence identical to the (19) or by a Student's t test.
natural IGF-I increases body length and weight as well as the weights of several organs of pituitary-deficient Snell dwarf mice RESULTS to a comparable degree as obtained after administration of bhGH. This confirms and extends our earlier data concerning Body growth. Rec-IGF-I at a dose of 7.4 pg/injection and the effects of semipurified SM-preparations (3, 4) . bhGH induced a significant increase in body length and weight
The overall harmony of growth during treatment with reccompared with phosphate buffer treated controls (Fig. 1) . Signif-IGF-I is sustained as shown by the weight/length ratio, which is icance was reached already after 2 wk of treatment. In contrast, not significantly different from that of bhGH. In general, organ 1.85 and 3.7 pg rec-IGF-I had only a slight and equal growth-growth is comparable using either rec-IGF-I or bhGH, although stimulating effect. The weight/length ratio of each mouse was the magnitude of the increase obtained under the present expercalculated at the beginning and the end of the experiment. The imental condition is not always the same. Future more detailed means of these ratio's were compared (Table I ). After 4 wk of studies with higher doses of rec-IGF-I will be needed to establish treatment all groups showed a significant increase of the weight/ whether or not there are differences in the effects on specific length ratio compared to the starting value ( p < 0.05). Both organs between rec-IGF-I and bhGH.
bhGH and rec-IGF-I (7.4 pg) induced a significant but similar increase over the controls. Lower doses of rec-IGF-I yielded intermediate values. after 4 wk of treatment was studied. In Table 2 Differences in body length between treated groups and controls were significant after 2 wk of treatment with rec-IGF-I (7.4 pg) ( p < 0.01) and bhGH ( p < 0.02); differences in body weight relative to the controls were also significant after 2 wk ( p < 0.02 for both substances by Student's t test).
There were no significant differences between both substances. Schoenle et al. ( 5 ) found a significant increase in body weight of hypophysectomized rats after treatment with 43 and 103 pg IGF-I per day during 6 days. In contrast our dwarf mice needed a higher doses of rec-IGF-I relative to body weight for a significant increase of body weight over controls. Due to the longer treatment period we were able to show that one of the most important indices of skeletal growth, namely body length, increased, hereby offering direct evidence supporting the somatomedin hypothesis (2) . Our data resolve the issue as to whether or not pure SM-C/IGF-I will induce growth in length and demonstrate the usefulness of recombinant IGF-I in the studies of growth regulation.
